Summary
Natco Pharma Limited (Natco Pharma) is a pharmaceutical company that focuses on the research, development, manufacture and commercialization of pharmaceutical substances and finished dosage forms. It offers finished dosage forms in capsule, injection and tablet forms. Its products are indicated to treat multiple sclerosis, influenza infection, multiple myeloma, leukemia, Crohn's disease, hypertension, Myelodysplastic syndrome and prostate cancer and others. Natco Pharma offers active pharmaceutical ingredients (APIs) for the domestic and international markets. It manages five API and finished dosage facilities and a research center in India. The company operates in India, the US, Canada, and Europe. Natco Pharma is headquartered in Hyderabad, Telangana, India.
Natco Pharma Limited (NATCOPHARM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Natco Pharma Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Natco Pharma Limited, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Natco Pharma Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Natco Pharma Limited, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Natco Pharma Limited, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Natco Pharma Limited, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Sun Pharma May Sell its Drugs 12
Partnerships 14
Natco Pharma Enters Into Agreement With MAbxience For Monoclonal Antibodies 14
Litha Pharma Partners with Natco Pharma 15
Renata Enters Into Joint Venture With Natco Pharma To Form Renata Oncology 16
Lupin Enters Into Co-Marketing Agreement With Natco Pharma 17
Natco Pharma Enters Into Co-Marketing Agreement With Celgene For Revlimid 18
Licensing Agreements 20
Cipla, Emcure Pharma, Hetero Drugs and Natco Pharma Enter into Licensing Agreement with Medicines Patent Pool and Bristol-Myers Squibb 20
Natco Pharma Enters into Licensing Agreement with Gilead Sciences 22
Watson Enters Into Licensing Agreement With Natco 23
Equity Offering 25
Natco Pharma Raises USD55 Million in Private Placement of Shares 25
Natco Pharma Completes Private Placement Of Shares For US$18 Million 26
Natco Pharma Completes Private Placement Of Shares For US$13.1 Million 27
Debt Offering 29
Natco Pharma Plans Private Placement Of Debentures For US$24.3 Million 29
Asset Transactions 30
Crystal Drugs Acquires Nicks Drugs Store From K & C Pharmacy 30
Acquisition 31
Kotak Private Equity Sells 1.18% Stake In Natco Pharma 31
Natco Pharma Acquires 51% Stake In Natco Organics From Tamilnadu Industrial Development 32
Time Cap Overseas Acquires 90% Stake In Uniao Distributors, Pharma Distributor 33
Natco Pharma Limited - Key Competitors 34
Key Employees 35
Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38
List of Tables
Natco Pharma Limited, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Natco Pharma Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Natco Pharma Limited, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Natco Pharma Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Natco Pharma Limited, Deals By Therapy Area, 2010 to YTD 2016 8
Natco Pharma Limited, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Sun Pharma May Sell its Drugs 12
Natco Pharma Enters Into Agreement With MAbxience For Monoclonal Antibodies 14
Litha Pharma Partners with Natco Pharma 15
Renata Enters Into Joint Venture With Natco Pharma To Form Renata Oncology 16
Lupin Enters Into Co-Marketing Agreement With Natco Pharma 17
Natco Pharma Enters Into Co-Marketing Agreement With Celgene For Revlimid 18
Cipla, Emcure Pharma, Hetero Drugs and Natco Pharma Enter into Licensing Agreement with Medicines Patent Pool and Bristol-Myers Squibb 20
Natco Pharma Enters into Licensing Agreement with Gilead Sciences 22
Watson Enters Into Licensing Agreement With Natco 23
Natco Pharma Raises USD55 Million in Private Placement of Shares 25
Natco Pharma Completes Private Placement Of Shares For US$18 Million 26
Natco Pharma Completes Private Placement Of Shares For US$13.1 Million 27
Natco Pharma Plans Private Placement Of Debentures For US$24.3 Million 29
Crystal Drugs Acquires Nicks Drugs Store From K & C Pharmacy 30
Kotak Private Equity Sells 1.18% Stake In Natco Pharma 31
Natco Pharma Acquires 51% Stake In Natco Organics From Tamilnadu Industrial Development 32
Time Cap Overseas Acquires 90% Stake In Uniao Distributors, Pharma Distributor 33
Natco Pharma Limited, Key Competitors 34
Natco Pharma Limited, Key Employees 35
Natco Pharma Limited, Other Locations 36
Natco Pharma Limited, Subsidiaries 37
List of Figures
Natco Pharma Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Natco Pharma Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Natco Pharma Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Natco Pharma Limited, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Natco Pharma Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Natco Pharma Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Natco Pharma Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Natco Pharma Limited, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
